Pyridines as FBPase inhibitors for treatment of diabetes
US8163778B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2008 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | May 25, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I)as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.